Status: Recruiting
Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interactions
The purpose of this study is to define and compare the pharmacokinetic (PK) and pharmacodynamic (PD) profile of EYP651 at two dose levels and compare it with Vonafexor Acid PK and PD profile, the Part A. In addition, Part B of the trial will assess the Drug-Drug Interactions (DDI) potential with the high dose of EYP651.
Participants needed: 40
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Enyo PharmaUpdated: Feb 27, 2026Locations: 1
Eligibility criteria
Healthy male or female subject, aged 18-65 years inclusive. [+11]
Any relevant history or presence of cardiovascular, pulmonary, gastro-intestinal... [+16]